317 results on '"Burridge, Paul W."'
Search Results
52. RARG variant predictive of doxorubicin-induced cardiotoxicity identifies a cardioprotective therapy
53. Modeling Cardiovascular Diseases with Patient-Specific Human Pluripotent Stem Cell-Derived Cardiomyocytes
54. Abstract P343: Physiologic Mechanical Stress In An Induced Pluripotent Stem Cell Derived Cardiomyocyte Model Of Duchene Muscular Dystrophy-related Cardiomyopathy Treated With A Membrane Resealant
55. Pravastatin reverses obesity-induced dysfunction of induced pluripotent stem cell-derived endothelial cells via a nitric oxide-dependent mechanism
56. A Review of Human Pluripotent Stem Cell-Derived Cardiomyocytes for High-Throughput Drug Discovery, Cardiotoxicity Screening, and Publication Standards
57. Targeting the Microtubule EB1-CLASP2 Complex Modulates Na V 1.5 at Intercalated Discs
58. An updated protocol for the cost-effective and weekend-free culture of human induced pluripotent stem cells
59. Generating a Cost-Effective Weekend-Free Chemically Defined hiPSC Culture Medium
60. Highly Efficient Directed Differentiation of Human Induced Pluripotent Stem Cells into Cardiomyocytes
61. Generation of Human iPSCs from Human Peripheral Blood Mononuclear Cells Using Non-integrative Sendai Virus in Chemically Defined Conditions
62. Use of hiPSC to explicate genomic predisposition to anthracycline-induced cardiotoxicity
63. Genetic Variants Associated with Therapy-Related Cardiomyopathy among Childhood Cancer Survivors of African Ancestry
64. Generation of Multipotent CD34+CD45+ Hematopoietic Progenitors from Human Induced Pluripotent Stem Cells
65. A physical map of the mouse genome
66. Cellular model systems to study cardiovascular injury from chemotherapy
67. GS-967 and Eleclazine Block Sodium Channels in Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes
68. Abstract 534: Chemically Defined Cell Culture Media for High Yield Differentiation of Functional Human Cardiac Myocytes
69. Abstract 251: Modeling LMNA Associated Cardiomyopathy Using Patient-Specific Human Induced Pluripotent Stem Cells
70. Generating a Cost‐Effective, Weekend‐Free Chemically Defined Human Induced Pluripotent Stem Cell (hiPSC) Culture Medium
71. Negligible-Cost and Weekend-Free Chemically Defined Human iPSC Culture
72. Physiological stress improves stem cell modeling of dystrophic cardiomyopathy
73. Genetic Mosaicism in Calmodulinopathy
74. Negligible-Cost and Weekend-Free Chemically Defined Human iPSC Culture
75. Dissociation of disease phenotype and allele silencing in hypertrophic cardiomyopathy
76. Are These Cardiomyocytes? Protocol Development Reveals Impact of Sample Preparation on the Accuracy of Identifying Cardiomyocytes by Flow Cytometry
77. Unraveling Difficult Answers: From Genotype to Phenotype in Coronary Artery Disease
78. hiPSCs in cardio-oncology: deciphering the genomics
79. Stage-specific Effects of Bioactive Lipids on Human iPSC Cardiac Differentiation and Cardiomyocyte Proliferation
80. Stage-specific Effects of Bioactive Lipids on Human iPSC Cardiac Differentiation and Cardiomyocyte Proliferation
81. Are these cardiomyocytes? Protocol development reveals impact of sample preparation on the accuracy of identifying cardiomyocytes by flow cytometry
82. Abstract 346: A Standard Flow Cytometry Protocol for Assessing Human Pluripotent Stem Cell-derived Cardiomyocyte Identity by Troponin Positivity
83. Stage-specific Effects of Bioactive Lipids on Human iPSC Cardiac Differentiation and Cardiomyocyte Proliferation
84. Doxorubicin induces caspase-mediated proteolysis of KV7.1
85. Human Induced Pluripotent Stem Cell (hiPSC)-Derived Cells to Assess Drug Cardiotoxicity: Opportunities and Problems
86. The future role of pharmacogenomics in anticancer agent-induced cardiovascular toxicity
87. Passive Stretch Induces Structural and Functional Maturation of Engineered Heart Muscle as Predicted by Computational Modeling
88. Plasminogen Activator Inhibitor Type I Controls Cardiomyocyte Transforming Growth Factor-β and Cardiac Fibrosis
89. Accurate nanoelectrode recording of human pluripotent stem cell-derived cardiomyocytes for assaying drugs and modeling disease
90. Validating the pharmacogenomics of chemotherapy-induced cardiotoxicity: What is missing?
91. Genetic Mosaicism in Calmodulinopathy.
92. Multi-cellular interactions sustain long-term contractility of human pluripotent stem cell-derived cardiomyocytes
93. Transcriptome Profiling of Patient-Specific Human iPSC-Cardiomyocytes Predicts Individual Drug Safety and Efficacy Responses In Vitro
94. Abstract 289: Transcriptomic Analysis of Inter- and Intra-patient Variation in Human iPSCs: Platform for Precision Medicine to Predict Drug Toxicity
95. Screening Adverse Drug-Induced Arrhythmia Events Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Low-Impedance Microelectrode Arrays
96. Genetic and Epigenetic Regulation of Human Cardiac Reprogramming and Differentiation in Regenerative Medicine
97. Chemically Defined Culture and Cardiomyocyte Differentiation of Human Pluripotent Stem Cells
98. Derivation of Highly Purified Cardiomyocytes from Human Induced Pluripotent Stem Cells Using Small Molecule-modulated Differentiation and Subsequent Glucose Starvation
99. Novel codon-optimized mini-intronic plasmid for efficient, inexpensive and xeno-free induction of pluripotency
100. Induced Pluripotent Stem Cells from Familial Alzheimer's Disease Patients Differentiate into Mature Neurons with Amyloidogenic Properties
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.